TrueBlue (TBI) director Kreidler receives 27,566 RSU grant and reports 85,381 shares

Rhea-AI Filing Summary

Kreidler Robert C. reported acquisition or exercise transactions in this Form 4 filing.

TrueBlue, Inc. director Robert C. Kreidler reported an equity award of 27,566 shares of common stock in the form of restricted stock units. These units will vest in full one year from the grant date and will be settled on a one-for-one basis in common shares.

Delivery of the vested shares to Kreidler will occur 90 days after his separation from service on the Board of Directors. Following this award, his directly held and deferred holdings total 85,381 shares, including 71,664 shares deferred under the company’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.

Insights

Equity Compensation Analyst

Routine director RSU grant increases reported holdings without cash purchase.

Robert C. Kreidler, a director of TrueBlue, Inc., received an award of 27,566 restricted stock units that convert into common stock on a one-for-one basis after vesting. This is characterized as a grant, award, or other acquisition, rather than an open-market share purchase.

The restricted stock units vest in full one year from the grant date, and the shares will be delivered 90 days after his separation from the Board. After this award, his reported total, including 71,664 shares deferred under a board compensation plan, is 85,381 shares. This reflects standard non-employee director compensation structure, so the directional impact on the investment thesis is neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kreidler Robert C.

(Last) (First) (Middle)

1015 A STREET

(Street)

TACOMA WA 98402

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TrueBlue, Inc. [ TBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		27,566(1)	A	$0	85,381(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors.

2. This total includes 71,664 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.

Remarks:

	/s/ Todd N. Gilman, Attorney-in-fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TrueBlue (TBI) director Robert C. Kreidler report?

Director Robert C. Kreidler reported an acquisition of 27,566 restricted stock units in TrueBlue common stock. These units are an equity award, not an open-market purchase, and will convert into shares on a one-for-one basis after vesting according to the award terms.

How do the new restricted stock units for TrueBlue (TBI) vest for director Robert C. Kreidler?

The 27,566 restricted stock units granted to Robert C. Kreidler vest in full one year from the grant date. Once vested, they are settled in TrueBlue common shares on a one-for-one basis, following the vesting schedule described in the award’s terms.

When will Robert C. Kreidler receive the vested TrueBlue (TBI) shares from this award?

Delivery of the vested shares to Robert C. Kreidler will occur 90 days after his separation from service on TrueBlue’s Board of Directors. This means the shares are deferred until after his board service ends, adding a long-term alignment component to the award.

How many TrueBlue (TBI) shares does Robert C. Kreidler report owning after this Form 4?

After this transaction, Robert C. Kreidler reports total holdings of 85,381 TrueBlue shares. This figure includes 71,664 shares deferred under the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors, as well as the newly reported restricted stock units award.

Are the 27,566 TrueBlue (TBI) restricted stock units a cash purchase by Robert C. Kreidler?

No, the 27,566 restricted stock units are described as a grant, award, or other acquisition, with a price per share of 0.0000. This indicates they are part of TrueBlue’s director compensation, not an open-market cash purchase of common stock by Kreidler.

What portion of Robert C. Kreidler’s TrueBlue (TBI) holdings is deferred compensation?

Of Robert C. Kreidler’s reported 85,381 TrueBlue shares, 71,664 shares are deferred under the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. This highlights that a significant portion of his reported holdings is tied to the company’s deferred board compensation program.